High affinity T cell receptor and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10626159
APP PUB NO 20180162921A1
SERIAL NO

15822970

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a high affinity T cell receptor (TCR) against a tumor-associated antigen, an isolated nucleic acid molecule encoding the same, a T cell expressing the TCR, and a pharmaceutical composition for use in the treatment of diseases involving malignant cells expressing the tumor-associated antigen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZINROBERT-ROESSLE-STRASSE 10 BERLIN 13125

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frankenberger, Bernhard Munich, DE 6 67
Schendel, Dolores Jean Munich, DE 5 19
Uckert, Wolfgang Berlin, DE 19 237
Wilde, Susanne Munich, DE 12 131

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 21, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 21, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00